PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

As genetic and biomarker tests become more common, so do new therapies that target specific tumor types and may lead to ...

It would be short-sided, erroneous and dangerous to think ill of mifepristone, which has several important applications,, M.D ...

Triple-positive breast cancer is a type of breast cancer that tests positive for estrogen receptors, progesterone receptors, and high levels of HER2 protein. Some types of breast cancer cells use ...

hypokalemia or QT prolongation – serious adverse events that can arise in patients taking currently approved medications – ...

Corcept Therapeutics (CORT) announced that the FDA filed its New Drug Application (NDA) submission for its proprietary, selective cortisol ...

Rise in prevalence of cancer and the necessary attention in early diagnosis and treatment to boost market demand, States Fact.MRRockville, MD, ...

By Kolade Adeyemo / Jambar Contributor Breast cancer is one of the most prevalent cancers worldwide, affecting millions of ...

Patients who undergo a medication abortion during the first trimester of pregnancy are at a significantly higher risk of ...